Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 27, 2026

Convocation de l’assemblée générale annuelle d’approbation des comptes 2025 prévue le 22 mai 2026 et évolution du conseil d’administration d’Atos

View original at globenewswire.com
Convocation de l’assemblée générale annuelle d’approbation des comptes 2025 prévue le 22 mai 2026 et évolution du conseil d’administration d’Atos Communiqué de presse Convocation de l’assemblée générale annuelle d’approbation des comptes 2025 prévue le 22 mai 2026 et évolution du conseil d’administration d’Atos Paris,…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Board of Directors decided to maintain the combined Chairman and CEO roles exercised by Philippe Salle if his director mandate is renewed

    60% confidence
  • Not proposing renewal of Mandy Metten's censeure mandate aligns with best governance practices and reflects that the position enabled transition after her employee representative director term

    60% confidence
  • Laurent Collet-Billon brings particularly relevant strategic perspective to the Board for the Group's activities based on his recognized experience in defense, security and digital sectors, notably as head of DGA

    60% confidence
  • The mandate renewals would ensure governance continuity and recognize the commitment, experience and valuable contributions of Philippe Salle and Laurent Collet-Billon to the Board's work and the Group's transformation

    60% confidence
  • Philippe Salle brings key competencies to the Board to continue implementing the strategic plan and transformation while ensuring governance continuity and stability, based on his experience leading public companies and understanding the Group's strategic, operational and financial challenges

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com